[ad_1]
According to an Associated Press report, the inaccurate detection of Wuhan pneumonia in China was due to secret transactions between the government and private companies. (Schematic diagram) Image: Xinhua News Agency
Wuhan pneumonia is harming the world and more than 64.52 million people have been diagnosed so far. China, where the first outbreak of the epidemic occurred, continued to shed its responsibilities and laughed at other countries for “copying China’s operations.” However, the “Associated Press” reported that confidential documents released by Chinese medical personnel and other insiders revealed that the Chinese Centers for Disease Control and Prevention received money from three companies in Shanghai and exclusively authorized the use of the screens they produced. However, the quality of these detection agents is so poor that no confirmed cases have been detected in China for a period of time. Therefore, the Chinese authorities have not adopted restrictions such as a ban on large gatherings and travel, causing the epidemic to spread rapidly and break out around the world.
According to an Associated Press report, the inaccurate detection of Wuhan pneumonia in China was caused by secret transactions between the government and private companies. The Associated Press investigated 40 doctors, CDC employees, health experts and insiders, obtained internal documents and emails, and found that China had transactions with three unknown Shanghai companies at the time. GeneoDx Biotech, Huirui Biotechnology, BioGerm Medical Technology, and three other companies paid the CDC money and requested anonymity to allow them the exclusive right to sell the test virus detection agent.
After completing secret transactions with the three Shanghai companies mentioned above, the CDC and the Chinese health unit tried to prevent other scientists and organizations from using their own detection agents for virus testing and only sent virus samples to their licensed laboratories. . Screening and selection agents produced by the three companies resulted in no new cases in China from January 5 to 17, and also caused officials to delay early actions to impose restrictions on large-scale meetings and travel. Studies have shown that while it is unclear whether this can curb the global pandemic, if China takes action two weeks early, it will reduce the number of cases by 86%.
According to statistics from the Imperial College of Technology in London, as of January 31, there were only 19 people suspected of being infected in Wuhan who had been tested, and only one person had been diagnosed. The other 18 people who were not diagnosed with suspicious detection agents were sent home. Start spreading the virus. On January 23, a teacher named Peng coughed for several days and went to the doctor. The hospital detected signs of infection in his lungs, but the test was negative until January 30. However, he continued with a fever and was checked again. at the request of his family. Finally, it was too late to test positive on day 4 and he died of Wuhan pneumonia a few weeks later.
The report notes that BioGerm, one of the three companies mentioned above, was established three years ago. The company employs less than 100 people. Compared to their peers with thousands of employees, they are severely understaffed. China’s three most famous companies However, no detection agent was created for this epidemic. An industry engineer said that “Shanghai’s competitors have sprung up like mushrooms after a rain shower,” but have never heard of these company names. Huang Yanzhong, senior global health researcher at the US Council on Foreign Relations, said that since only three companies in China provide screening agents, testing capacity is very limited. This is mainly due to the increase in the number of cases and deaths.
The Associated Press stated that they obtained hundreds of internal emails, noting that the three companies mentioned above had a large number of contacts with researchers from the Chinese Centers for Disease Control and Prevention in Beijing and Shanghai, and the Chinese regulatory agency. banned Associated Press Credit reports of these companies have been obtained and are called confidential companies during the epidemic It is currently unknown if the three companies have violated Chinese laws, but they may have been involved in bribery. “The Associated Press” has also repeatedly asked the Chinese Foreign Ministry and the National Health Commission, but declined to answer.
Wuhan pneumonia is harming the world and more than 64.52 million people have been diagnosed so far. China, where the first outbreak of the epidemic occurred, continued to “shake the pot” and shirked its responsibilities, laughing at other countries for “copying China’s operations.” However, the Associated Press reported that Chinese medical personnel and other insiders obtained confidential documents and revealed that the Chinese Center for Disease Control and Prevention received money from three companies in Shanghai and exclusively authorized the use of detection agents. produced by these three companies. However, the quality of these detection agents is so poor that no confirmed cases have been detected in China for a period of time. Therefore, the Chinese authorities have not adopted restrictions such as a ban on large gatherings and travel, which caused the epidemic to spread rapidly and break out around the world.
According to an Associated Press report, the inaccurate detection of Wuhan pneumonia in China was caused by secret transactions between the government and private companies. China has transactions with three unknown Shanghai companies. GeneoDx Biotech, Huirui Biotechnology, BioGerm Medical Technology, and three other companies paid the CDC money and requested anonymity to allow them the exclusive right to sell the virus test. As a result, China did not have any new cases from January 5 to 17, and it also caused officials to delay early actions to impose restrictions on large-scale meetings and travel.
[ad_2]
